Gene expression of TFPI2 was decreased in samples of bladder tumors (43) and cervical tumors (44), while TFPI2 protein concentrations in serum were higher in ovarian clear cell adenocarcinoma patients (45, 46). Here, TFPI2 is linked to uterine cervix neoplasm.